Drug Database
Back to search

Belgium· BE-AMP-SAM555813-00

Ticlid 250 mg

A ticlopidine product containing ticlopidine hydrochloride, registered in Belgium by Impexeco. The same ATC class is registered in 7 of our 19 countries.

ATC B01AC05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTiclid 250 mgATCB01AC05REGISTER NO.BE-AMP-SAM555813-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ticlopidine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ticlopidine is registered in 7 of 19 countries.

Countries holding a registration under ATC B01AC05 (ticlopidine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 5 of them publish a price we can compare per daily dose
Search ticlopidine products by name

Ticlopidine · ATC B01AC05

7 / 19 countries

  • Belgiumprice
  • Franceprice
  • Germany
  • Italyprice
  • Polandprice
  • Spainprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ticlopidine costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.25 in Italy to $1.0 in France — a ×4.0 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Ticlopidine · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • FR France$1.0
  • ES Spain$0.71
  • IT Italy$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ticlopidine Hydrochloride
Manufacturer
Impexeco
Country
Belgium (BE)
ATC code
B01AC05
ATC class
Ticlopidine
Defined daily dose
0.5 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    2683167
    EUR 23.52
  • be_apb
    7728736

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

318 interactions on record for ticlopidine.

Graded by severity as the source publishes them — 54 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ticlopidine against other medicinesHow interaction checks work

Ticlopidine · interactions on record

318 records

  • 54 severe
  • 124 moderate
  • 36 minor
  • 104 info

Most severe, free to view

  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe
  • TinzaparinB01AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ticlopidine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ticlopidine products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Germany · Ticlopidin Neuraxpharm, Ticlopidine Ratiopharm
  • Spain · Ticlopidina Cinfa
  • France · Ticlopidine Arrow, Ticlopidine Eg
  • Greece · Ruxicolan Cap
  • Hungary · Aclotin, Ticlid
  • Italy · Chiaro, Clox
  • Luxembourg · Ticlid
  • Poland · Aclotin
  • Portugal · Ticlopidina, Ticlopidina Alter
  • Romania · Ticlodin
  • Slovakia · Ticlopidin Ratiopharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1af2bad6-7fc8-45ee-b013-ff63f7a45d8c
GET /v1/drugs/1af2bad6-7fc8-45ee-b013-ff63f7a45d8c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Ticlid 250 mg",
  "name_fr": "Ticlid 250 mg",
  "name_nl": "Ticlid 250 mg",
  "amp_code": "SAM555813-00",
  "strengths": [
    "250.0000",
    "250.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Ticlopidine Hydrochloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ticlopidine",
  "authorisation_numbers": [
    "1549PI0353F003"
  ]
}
API referenceMCP serverPlans

See everything about ticlopidine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console